Human papillomavirus

Overview of Treatment

The treatment of Human Papillomavirus (HPV) infection primarily targets diseases caused by high-risk or low-risk HPV types, including cervical intraepithelial neoplasia, genital warts, oropharyngeal cancers, and others. The goal of treatment is to eradicate the virus, inhibit lesion progression, reduce cancer risk, and prevent transmission. Depending on the infection type and severity, treatment options include medication, surgical removal, vaccination, and immune modulation strategies.

Such treatments should be combined with regular screening and medical monitoring to achieve optimal prevention and therapeutic outcomes. For example, patients with cervical intraepithelial neoplasia typically require Pap smear tests and HPV DNA testing to evaluate treatment efficacy and monitor for recurrence.

Types and Mechanisms of Treatment

1. Antiviral Drugs: Such as interferons, which work by enhancing the host immune response and suppressing viral replication. Topical immune modulators (e.g., imiquimod cream) can induce local inflammatory reactions to promote lesion healing.

2. Surgical Procedures: Including Loop Electrosurgical Excision Procedure (LEEP) or cryotherapy, which directly remove visible lesions. These invasive treatments are suitable for high-grade precancerous lesions or visibly identifiable genital warts.

3. Vaccination: HPV vaccines are preventive, stimulating antibody production to block virus binding to host cells. Currently available vaccines include bivalent, quadrivalent, and nonavalent types, covering different high-risk and low-risk HPV strains.

Indications

Applicable to the following clinical symptoms:

  • Cervical intraepithelial neoplasia (CIN 1-3) or high-grade dysplasia
  • Genital warts on the vulva, perianal area, or oral mucosa
  • Persistent HPV infection (infection exceeding 2 years)

Differences in indications for specific treatments:

  • Surgical treatment: suitable for CIN 2-3 or extensive lesions
  • Medication: suitable for mild lesions or patients refusing surgery
  • Vaccination: recommended for uninfected individuals aged 9-45 for prevention

Usage and Dosage

Most medications are applied locally or injected:

  • Imiquimod cream: applied three times weekly, with each application not exceeding 12 hours
  • Cidofovir: use according to medical instructions to adjust frequency and dosage

Vaccination schedule:

  • Bivalent vaccine: 2-3 doses spaced 6 months apart
  • Nonavalent vaccine: 2 doses for those under 15 years old, 3 doses for those 15 and older

Benefits and Advantages

Preventive vaccines can reduce 70-90% of HPV-related cancers, with antibody levels maintained for over 10 years. Surgical removal can immediately eliminate visible lesions and reduce the risk of progression. Immune-modulating drugs stimulate local immune responses, decreasing recurrence rates.

Compared to traditional chemotherapy, current treatment options offer the following advantages:

  • Non-invasive procedures reduce tissue damage
  • Cost-effective vaccination suitable for large-scale public health programs
  • Multiple treatment modalities can be combined based on condition

Risks and Side Effects

Medications may cause local irritation, such as redness, blistering, or peeling. About 5-10% of patients using imiquimod may experience severe skin allergies. Surgical treatments may carry risks of tissue damage, bleeding, or infection.

Serious side effects include:

  • Post-vaccination pain at injection site, fever, and systemic reactions
  • Immune modulation therapy may trigger autoimmune responses
  • Postoperative complications such as cervical stenosis or infertility (applicable to cervical lesion treatments)

Precautions and Contraindications

Contraindications include:

  • Allergy to vaccine components
  • Immunodeficiency patients should use immune modulators cautiously
  • Avoid topical medications during pregnancy

Precautions for use:

  • Avoid sexual activity or use protection during treatment
  • Complete full vaccination doses to ensure adequate protection
  • Regular follow-up to monitor cervical tissue recovery post-surgery

Interactions with Other Treatments

Concurrent use with chemotherapy drugs may enhance immune responses, requiring dose adjustments. Use of immunosuppressants like steroids may reduce vaccine efficacy, necessitating delayed vaccination. Post-surgical use of antiviral drugs should consider drug metabolism interactions.

Recommendations for interval between other vaccines:

  • HPV vaccination and cervical cancer screening should be spaced at least 2 weeks apart
  • Can be administered simultaneously with influenza vaccine at different injection sites

Effectiveness and Evidence

Clinical trials show that HPV vaccination provides up to 98% protection against HPV types 16/18, reducing the risk of cervical intraepithelial neoplasia by 70%. Surgical excision of lesions can lower recurrence rates within 5 years to below 10%.

Long-term follow-up studies indicate:

  • Antibody levels in vaccinated individuals remain protective after 10 years
  • Combining vaccination with regular screening can reduce cervical cancer mortality by 60%

Alternative Options

For those unsuitable for surgery:

  • Photodynamic therapy: using specific wavelength light to destroy abnormal cells
  • Cryotherapy: freezing lesions with liquid nitrogen

Alternative medications include:

  • Oral antiviral drugs (e.g., cidofovir)
  • Gene therapy: using RNA interference to block viral gene expression

 

Frequently Asked Questions

How to correctly use topical anti-HPV ointments to improve treatment effectiveness?

When applying topical ointments, first clean the affected area and keep it dry. After it is completely dry, apply the medication, using it regularly as prescribed, and avoid contact with healthy skin. During treatment, do not scratch or disturb the lesions, and return for regular follow-up visits to evaluate efficacy, ensuring proper absorption and reducing infection risk.

Can I engage in sexual activity during HPV treatment? What precautions should I take?

Sexual activity can be continued cautiously during treatment, but protection such as condoms should be used throughout, and contact with lesions should be avoided. If lesions are located in the genital area, it is recommended to suspend sexual activity until the physician confirms lesion resolution, and partners should also be examined to reduce transmission and re-infection risks.

What daily habits may affect the efficacy of immune therapy?

Avoid smoking and alcohol, maintain regular exercise and a balanced diet to boost immunity, which can enhance treatment effectiveness. During therapy, avoid using other medications or folk remedies, and follow the prescribed medication schedule. Excessive cleaning or irritating the lesions may delay healing.

Does disappearance of lesions after treatment mean HPV is completely cleared? How long should follow-up continue?

Lesion disappearance indicates symptomatic improvement, but HPV may still persist in the body. Continued follow-up for at least 2 years is necessary. Doctors will schedule regular tests, including cytology or viral load measurements, based on virus type and immune status, to detect early signs of recurrence.

After HPV vaccination, is additional treatment still necessary?

The vaccine mainly prevents infection with types not yet infected. Existing HPV infections still require targeted treatment. If infected with strains outside the vaccine coverage, topical medications, surgery, or immune therapies may be needed based on lesion type, as the vaccine cannot directly eliminate current infections.